SCHEMBL4769478

SCHEMBL4769478

O=Cc1ccc(/C=C/c2ccc(N(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
CYP2A6 P11509 2/20 0.52
RELA Q04206 1/20 0.50
ALDH3A1 P30838 1/20 0.50
ALDH1A3 P47895 1/20 0.50
CYP2A13 Q16696 1/20 0.48
APP P05067 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KMT2A Q03164 4/20 0.43
CTDSP1 Q9GZU7 1/20 0.42
MEN1 O00255 3/20 0.42
TLR9 Q9NR96 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769486 1.00 ALDH1A1 (0.52) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL4242047 0.98 ALDH1A1 (0.56) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL4242053 0.98 ALDH1A1 (0.56) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL2199745 0.94 ALDH1A1 (0.59) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL28032989 0.94 ALDH1A1 (0.59) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL181026 0.94 ALDH1A1 (0.59) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL851178 0.94 ALDH1A1 (0.59) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL13649928 0.94 ALDH1A1 (0.59) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL806381 0.91 ALDH1A1 (0.58) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3
SCHEMBL3181867 0.91 ALDH1A1 (0.58) ALDH1A1CYP2A6RELAALDH3A1ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026089560-A1 NOVEL NEAR-INFRARED PHOSPHOR COMPOUND AND USES THEREOF 서울대학교산학협력단 2026-04-30 WO disclosed
EP-3621957-B1 FUSED STILBENE DERIVATIVES AS SOLAR CELL DYES AMBIENT PHOTONICS INC (US) 2023-08-23 EP disclosed
US-11664171-B2 Stilbene and fused stilbene derivatives as solar cell dyes Ambient Photonics, Inc. (US) 2023-05-30 US disclosed
US-11664171-B2 Stilbene and fused stilbene derivatives as solar cell dyes Ambient Photonics, Inc. (US) 2023-05-30 US disclosed
US-20230154691-A1 Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes Ambient Photonics, Inc. (US) 2023-05-18 US disclosed
US-20230154691-A1 Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes Ambient Photonics, Inc. (US) 2023-05-18 US disclosed
CN-113583031-B Endoplasmic reticulum positioning imaging/photoinduced iron death dual-function probe 江西师范大学 2022-07-26 CN disclosed
US-11286233-B2 Stilbene derivatives for the treatment of CNS and other disorders Ambient Photonics, Inc. (US) 2022-03-29 US disclosed
CN-113583031-A Endoplasmic reticulum positioning imaging/photoinduced iron death dual-function probe 江西师范大学 2021-11-02 CN disclosed
US-20210114976-A1 Stilbene Derivatives for the Treatment of CNS and Other Disorders Ambient Photonics, Inc. (US) 2021-04-22 US disclosed
US-20210082632-A1 Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes Ambient Photonics, Inc. (US) 2021-03-18 US disclosed
EP-1424942-B1 PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY UNIV MONTANA STATE (US) 2008-12-31 EP disclosed
US-6953570-B2 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy MONTANA STATE UNIVERSITY (US) 2005-10-11 US disclosed
US-20030105070-A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy NICKEL JOINT TRUST, THE 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105070-A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy HMBS, PPOX, PAICS ALDH1A1 2239/4885CYP2A6 810/4885RELA 1712/4885
US-20210114976-A1 Stilbene Derivatives for the Treatment of CNS and Other Disorders CLN6, MAPT, PSEN2 ALDH1A1 2357/4885CYP2A6 4731/4885RELA 3247/4885
US-11286233-B2 Stilbene derivatives for the treatment of CNS and other disorders CLN6, MAPT, PSEN2 ALDH1A1 2357/4885CYP2A6 4731/4885RELA 3247/4885
US-20230154691-A1 Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes FDFT1, SUN2, CDC73 ALDH1A1 352/4885CYP2A6 3770/4885RELA 3395/4885
US-11664171-B2 Stilbene and fused stilbene derivatives as solar cell dyes SUN2, FDFT1, SIK1 ALDH1A1 406/4885CYP2A6 3785/4885RELA 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.